org placeholder image

Thomas Vancott

Chief Scientific Officer at Combined Therapeutics

  • LinkedIn

Email Email: t****@combinedtx.com

phone noPhone Number: (***)-***-****

Strategic C-level executive who has consistently succeeded in increasingly demanding managerial and strategic positions. Anticipating the critical bioservices market to meet biotech’s gr...

Read More

map
COMBINED THERAPEUTICS

COMBINED THERAPEUTICS

  • description Description
    Combined Therapeutics has developed a unique modified mRNA platform which targets protein expression to specific tissues while reducing off target effects. Together with our partners, we are ...

    Read More

  • Employees count Employees 11-50
  • Revenue Revenue Under 1 Million
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Combined Therapeutics Org Chart and Mapping

Employees

Frequently Asked Questions Regarding Thomas Vancott

Answer: Thomas Vancott works for Combined Therapeutics as Chief Scientific Officer

Answer: Thomas Vancott’s role in Combined Therapeutics is Chief Scientific Officer

Answer: Thomas Vancott's email address is t***@gmail.com

Answer: Thomas Vancott's business email address is t****@combinedtx.com

Answer: Thomas Vancott’s direct phone number is (***)-***-****

Answer: Thomas Vancott works in the industry of: Biotechnology

Answer: Thomas Vancott is the current Chief Scientific Officer at Combined Therapeutics.... Read More

Answer: Thomas Vancott works Combined Therapeutics located at 40 Guest St, Boston, , 2135, Massachusetts, United States

Answer: Combined Therapeutics's Chief Scientific Officer is Thomas Vancott

Answer: Thomas Vancott contact details:

  • Phone number  :  (***)-***-****
  • Email  :  t****@combinedtx.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access